Apax Development Acquires Majority Stake in Porsolt

Catalyst Clinical Research Acquires Aptus Clinical

May 4, 2022

Healthcare Services

Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.

Apax Partners and Fremman Capital acquire co-controlling stakes in Palex Medical

August 1, 2023

Medical Devices

Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.

Abenex and Arkéa Capital Acquire Majority Stake in Prévost Laboratory Concept

May 11, 2020

Manufacturing

Abenex (via Abenex Croissance) has acquired a majority stake in Prévost Laboratory Concept, a Nouvoitou, France-based contract laboratory that formulates, produces and packages cosmetics, food supplements and animal care products. The deal is supported by Arkéa Capital and founder Véronique Prévost (who remains chairman); the company employs ~30 people and generates about €8 million in revenue and will pursue accelerated organic and international growth.

Apax Partners Development Acquires Majority Stake in DIAPASON

November 20, 2020

Software

Apax Partners Development has taken a majority stake in DIAPASON, a France-based treasury, payments and risk management software provider. Apax will support DIAPASON's growth—targeting larger corporates and the mid-market, international expansion, and add-on acquisitions—while founder Pascal Kravitzch and the management team remain significant investors.

Novo Holdings Acquires Altasciences from Audax Private Equity

February 22, 2021

Healthcare Services

Novo Holdings has agreed to acquire Altasciences, a Laval, Canada–headquartered contract research and CDMO services provider, from Audax Private Equity. Altasciences— which operates six facilities across the U.S. and Canada and employs over 1,300 people—will remain led by CEO Chris Perkin and is expected to continue expanding domestically and internationally under Novo Holdings' ownership.

Investcorp Acquires Sanos Group

December 14, 2020

Healthcare Services

Investcorp has acquired Sanos Group, a Denmark-based contract research organization (CRO) specialized in osteoarthritis clinical trials and site management. Investcorp said it will support Sanos' international expansion and growth into additional therapeutic areas and geographies, including expanding its research clinic network.